MY102991A - Medicaments for treating hypertension. - Google Patents

Medicaments for treating hypertension.

Info

Publication number
MY102991A
MY102991A MYPI87003001A MYPI19873001A MY102991A MY 102991 A MY102991 A MY 102991A MY PI87003001 A MYPI87003001 A MY PI87003001A MY PI19873001 A MYPI19873001 A MY PI19873001A MY 102991 A MY102991 A MY 102991A
Authority
MY
Malaysia
Prior art keywords
medicaments
treating hypertension
compound
formula
combination
Prior art date
Application number
MYPI87003001A
Inventor
P Horovitz Zola
Rubin Bernard
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY102991(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of MY102991A publication Critical patent/MY102991A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A METHOD FOR REDUCING BLOOD PRESSURE COMPRISES ADMINISTERING A COMBINATION OF A DIURETIC COMPOUND AND A COMPOUND HAVING THE GENERAL FORMULA (FORMULA 1)
MYPI87003001A 1977-12-27 1987-10-31 Medicaments for treating hypertension. MY102991A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27
DE2854316A DE2854316C3 (en) 1977-12-27 1978-12-15 Medicines for the treatment of high pressure
GB7849703A GB2010675B (en) 1977-12-27 1978-12-21 Treating hypertension and medicaments therefor

Publications (1)

Publication Number Publication Date
MY102991A true MY102991A (en) 1993-03-31

Family

ID=25343256

Family Applications (2)

Application Number Title Priority Date Filing Date
MY240/83A MY8300240A (en) 1977-12-27 1983-12-30 Medicamens for treating hypertension
MYPI87003001A MY102991A (en) 1977-12-27 1987-10-31 Medicaments for treating hypertension.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MY240/83A MY8300240A (en) 1977-12-27 1983-12-30 Medicamens for treating hypertension

Country Status (30)

Country Link
JP (1) JPS54110333A (en)
AR (1) AR230378A1 (en)
AU (1) AU526239B2 (en)
BE (1) BE873092A (en)
CA (1) CA1120400A (en)
CH (1) CH642542A5 (en)
DE (1) DE2854316C3 (en)
DK (1) DK578778A (en)
EG (1) EG14178A (en)
FI (1) FI783991A (en)
FR (1) FR2413089A1 (en)
GB (1) GB2010675B (en)
GR (1) GR72951B (en)
HK (1) HK45483A (en)
HU (1) HU178747B (en)
IE (1) IE48306B1 (en)
IL (1) IL56281A (en)
IT (1) IT1202811B (en)
KE (1) KE3235A (en)
LU (1) LU80709A1 (en)
MY (2) MY8300240A (en)
NL (2) NL192870C (en)
NO (1) NO784357L (en)
NZ (1) NZ189159A (en)
PH (1) PH22111A (en)
PL (1) PL212188A1 (en)
PT (1) PT68983A (en)
SE (1) SE445173B (en)
SG (1) SG41482G (en)
ZA (1) ZA786948B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (en) * 1978-10-05 1983-06-25 ウェルファイド株式会社 Cyclic iminocarboxylic acid derivatives and their salts
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (en) * 1985-09-09 1987-03-26 Hoechst Ag PHARMACEUTICAL PREPARATION FOR TREATING HIGH PRESSURE
DK9200258U4 (en) * 1992-03-11 1993-07-23 Merck & Co Inc Pharmaceutical preparation containing enalapril for use in hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
IE782413L (en) 1979-06-27
GR72951B (en) 1984-01-17
FR2413089B1 (en) 1980-12-26
AU4204178A (en) 1979-07-05
HK45483A (en) 1983-10-28
PL212188A1 (en) 1980-02-11
IL56281A0 (en) 1979-03-12
AU526239B2 (en) 1982-12-23
KE3235A (en) 1982-11-05
LU80709A1 (en) 1979-04-13
FI783991A (en) 1979-06-28
DE2854316C3 (en) 1994-12-22
IE48306B1 (en) 1984-12-12
CA1120400A (en) 1982-03-23
NL980017I1 (en) 1998-07-01
JPS54110333A (en) 1979-08-29
JPS647045B2 (en) 1989-02-07
DE2854316A1 (en) 1979-07-05
CH642542A5 (en) 1984-04-30
NO784357L (en) 1979-06-28
NL192870C (en) 1998-04-02
GB2010675B (en) 1982-06-16
NZ189159A (en) 1984-12-14
FR2413089A1 (en) 1979-07-27
PT68983A (en) 1979-01-01
NL7812164A (en) 1979-06-29
SE7813277L (en) 1979-06-28
ZA786948B (en) 1980-04-30
IT7831266A0 (en) 1978-12-22
PH22111A (en) 1988-06-01
DE2854316C2 (en) 1989-08-10
HU178747B (en) 1982-06-28
GB2010675A (en) 1979-07-04
MY8300240A (en) 1983-12-31
IL56281A (en) 1983-05-15
SG41482G (en) 1985-01-11
DK578778A (en) 1979-06-28
AR230378A1 (en) 1984-04-30
SE445173B (en) 1986-06-09
BE873092A (en) 1979-06-27
NL192870B (en) 1997-12-01
EG14178A (en) 1984-06-30
IT1202811B (en) 1989-02-09

Similar Documents

Publication Publication Date Title
DE3364150D1 (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
UA5953A1 (en) Method for synthesizing sulfonylurea derivatives
DE3687007D1 (en) 6-thioxanthinderivate.
MY106263A (en) Method for the treatment or prevention of intrinsically aged skin with retinoids
ES525786A0 (en) A PROCEDURE FOR PREPARING DERIVATIVES OF PIRAZOLO (3,4-B) PIRIDINE
MY102991A (en) Medicaments for treating hypertension.
EP0122831A3 (en) Benzothiazole-2-sulfonamide derivatives for the topical treatment of elevated intraocular pressure
AU5516590A (en) Dehydrocholecalciferol derivatives
IE46171L (en) N-pyrrolidinylmethylbenzamide derivative.
ZA866810B (en) A pharmaceutical composition for the treatment of high blood pressure
ZA842959B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
IE780132L (en) Tetrazole derivatives
AU3230578A (en) Bicyclo (3, 2, 0) heptane derivatives
EP0458537A3 (en) Therapeutic compound for the treatment of bronchitis
ZA842665B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
PT85602A (en) Oxolabdanes a process for their preparation and their use as medicaments
UA16000A1 (en) Method for treatment of hypotrophy in piglings
JO1493B1 (en) Pharmaceutical compositions for the treatment of high blood pressure
ZA824941B (en) Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
DE2961870D1 (en) Use of (z)9-tetradecenylacetate and/or (z)9, (e)12- tetradecadienylacetate for attracting and combating panolis flammea
EP0155214A3 (en) 2-sulfamoyl-1h-indole derivatives for the treatment of elevated intraocular pressure
JPS5430181A (en) 3,4-dihydrocarbostyril derivative
JPS5427559A (en) 1-(4-butyl) benzoylpyrrolidine and bactericides containing the same
ES8301486A1 (en) 1-N-( alpha hydroxy - omega - aminoalkanoyl) derivatives of deoxykanamycin B compounds